EUVIMEDEUVIMED entdecken
Crossref

Global Incidence of Ovarian Cancer According to Histologic Subtype: A Population-Based Cancer Registry Study

Minmin Wang iD, Yanxin Bi, Yinzi Jin iD, Zhi-Jie Zheng iD

JCO Global Oncology · 2024-05 · (10)

DOI: 10.1200/go.23.00393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Global Oncology, 2024-05. Verfasst von Minmin Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Health, School of Public Health, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Registries. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Ovarian cancer can be categorized into distinct histologic subtypes with varying identifiable risk factors, molecular composition, clinical features, and treatment. The global incidence of ovarian cancer subtypes remains limited, especially in low- and middle-income countries (LMICs) without high-quality cancer registry systems. MATERIALS AND METHODS We used data from population-based cancer registries of the Cancer Incidence in Five Continents project to calculate the proportions of serous, mucinous, endometrioid, clear cell, and other histologic subtypes of ovarian cancer. Proportions were applied to the estimated numbers of patients with ovarian cancer from Global Cancer Observatory 2020. Age-standardized incidence rates were calculated. RESULTS Globally, an estimated 133,818 new patients of serous cancer, 35,712 new patients of mucinous cancer, 29,319 new patients of endometrioid cancer, and 17,894 new patients of clear cell cancer were identified in 2020. The distribution of ovarian cancer histologic subtypes exhibited regional variation. Eastern Europe had the highest rate of serous and mucinous carcinomas, whereas Northern Africa and Eastern Asia had the highest burden of endometrioid and clear cell carcinomas, respectively. CONCLUSION This study provides a global incidence landscape of histologic subtypes of ovarian cancer, particularly in LMICs lacking comprehensive registry systems. Our analysis offers valuable insights into disease burden and guidance for tailored strategies for prevention of ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsRegistriesHumansFemaleIncidenceMiddle AgedGlobal HealthAdultAgedAdenocarcinoma, MucinousCarcinoma, EndometrioidAdenocarcinoma, Clear Cell

Autor:innen und Institutionen

  • Department of Global Health, School of Public Health, Peking University, Beijing, China.
  • Institute for Global Health and Development, Peking University, Beijing, China.

ORCID-Profile: Minmin Wang, Yinzi Jin, Zhi-Jie Zheng

Zitieren

APA

Wang, M., Bi, Y., Jin, Y., & Zheng, Z. J. (2024). Global Incidence of Ovarian Cancer According to Histologic Subtype: A Population-Based Cancer Registry Study. JCO Global Oncology. https://doi.org/10.1200/go.23.00393

Vancouver

Wang M, Bi Y, Jin Y, Zheng ZJ. Global Incidence of Ovarian Cancer According to Histologic Subtype: A Population-Based Cancer Registry Study. JCO Global Oncology. 2024. doi:10.1200/go.23.00393

BibTeX
@article{Wang2024,
  author = {Wang, Minmin and Bi, Yanxin and Jin, Yinzi and Zheng, Zhi-Jie},
  title = {Global Incidence of Ovarian Cancer According to Histologic Subtype: A Population-Based Cancer Registry Study},
  journal = {JCO Global Oncology},
  year = {2024},
  number = {10},
  doi = {10.1200/go.23.00393}
}
Kostenlos starten →